ARROWHEAD PHARMACEUTICALS IN (ARWR)

US04280A1007 - Common Stock

24.44  +0.31 (+1.28%)

After market: 24.44 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-9-30)
2022
(2022-9-30)
2021
(2021-9-30)
2020
(2020-9-30)
Revenue
181.75M240.70M243.20M138.30M88.00M
Minority Interest Expense
6.05M4.00M400.00KN/AN/A
Operating Expenses
481.12M445.70M421.70M287.30M181.20M
Research and Development
362.33M332.00M281.20M199.00M123.50M
Selling, General, and Administrative Expenses
104.87M101.30M130.10M80.10M51.70M
Operating Income
-299.38M-205.00M-178.50M-149.00M-93.20M
Interest Income/Expense
-5.44M-3.00M5.00M6.10M9.20M
Other Income/Expense
1.44M1.50M800.00K2.10M-600.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-303.38M-206.50M-172.70M-140.80M-84.60M
Income Tax
-588.00K2.80M3.80M0.000.00
Net Income
-296.74M-205.30M-176.10M-140.80M-84.60M
EBITDA
-285.32M-192.50M-168.10M-140.70M-87.30M
 
Per Share Data
EPS Diluted Total Ops
-2.77-1.92-1.67-1.36-0.84
Non GAAP EPS
-2.77-1.92-1.68-1.36-0.84
 
Statistics
Profit Margin
-163.27%-85.29%-72.41%-101.81%-96.14%
Operating Profit Margin
-164.72%-85.17%-73.40%-107.74%-105.91%

All data in USD

Charts